"metastatic disease" trang 3 - tải miễn phí từ tailieuXANH
CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors
6    41    0
Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma

Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma
11    74    0
CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors

CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors
13    66    0
Survival and prognostic factors in conventional central chondrosarcoma

Survival and prognostic factors in conventional central chondrosarcoma
10    45    0
New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: A nested case–control study in UK general practice

New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: A nested case–control study in UK general practice
11    74    0
Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: The NIKOLO trial

Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: The NIKOLO trial
7    53    0
Vemurafenib in Chinese patients with BRAFV600 mutation–positive unresectable or metastatic melanoma: An open-label, multicenter phase I study

Vemurafenib in Chinese patients with BRAFV600 mutation–positive unresectable or metastatic melanoma: An open-label, multicenter phase I study
7    73    0
Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer

Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer
10    58    0
Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer

Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer
10    50    0
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
11    63    0
Biopsy of breast cancer metastases: Patient characteristics and survival

Biopsy of breast cancer metastases: Patient characteristics and survival
9    59    0
Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells

Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells
11    51    0
The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: An observational cohort study in Denmark

The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: An observational cohort study in Denmark
11    54    0
Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells

Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells
16    59    0
Colorectal liver metastatic disease: Efficacy of irreversible electroporation - a single-arm phase II clinical trial (COLDFIRE-2 trial)

Colorectal liver metastatic disease: Efficacy of irreversible electroporation - a single-arm phase II clinical trial (COLDFIRE-2 trial)
7    50    0
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
10    51    0
Prognostic factors of metastatic myxoid liposarcoma

Prognostic factors of metastatic myxoid liposarcoma
10    53    0
How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease - decision analysis and comparison of three international patient populations

How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease - decision analysis and comparison of three international patient populations
8    71    0
Blood transcript analysis and metastatic recurrent small bowel carcinoid management

Blood transcript analysis and metastatic recurrent small bowel carcinoid management
5    63    0
Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
9    54    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.